Helius Medical Technologies, Inc.

NasdaqCM:HSDT Stock Report

Market Cap: US$1.6m

Helius Medical Technologies Management

Management criteria checks 2/4

Helius Medical Technologies' CEO is Dane Andreeff, appointed in Aug 2020, has a tenure of 4.25 years. total yearly compensation is $1.64M, comprised of 23.6% salary and 76.4% bonuses, including company stock and options. directly owns 0.001% of the company’s shares, worth $13.13. The average tenure of the management team and the board of directors is 3.4 years and 7.3 years respectively.

Key information

Dane Andreeff

Chief executive officer

US$1.6m

Total compensation

CEO salary percentage23.6%
CEO tenure4.3yrs
CEO ownership0.0008%
Management average tenure3.4yrs
Board average tenure7.3yrs

Recent management updates

Recent updates

Helius Medical Technologies: A Net-Net Meme Stock In The Making

Aug 23

Helius Medical Technologies stock slides 51% after pricing $18M securities offering

Aug 05

We Think Helius Medical Technologies (NASDAQ:HSDT) Needs To Drive Business Growth Carefully

Aug 18
We Think Helius Medical Technologies (NASDAQ:HSDT) Needs To Drive Business Growth Carefully

Helius Medical makes CEO, CFO appointments

Jun 15

Helius Medical Technologies announces reverse stock split

Dec 31

Helius Medical Technologies EPS beats by $0.01, beats on revenue

Nov 12

CEO Compensation Analysis

How has Dane Andreeff's remuneration changed compared to Helius Medical Technologies's earnings?
DateTotal CompensationSalaryCompany Earnings
Sep 30 2024n/an/a

-US$9m

Jun 30 2024n/an/a

-US$9m

Mar 31 2024n/an/a

-US$9m

Dec 31 2023US$2mUS$386k

-US$9m

Sep 30 2023n/an/a

-US$13m

Jun 30 2023n/an/a

-US$10m

Mar 31 2023n/an/a

-US$12m

Dec 31 2022US$603kUS$368k

-US$14m

Sep 30 2022n/an/a

-US$13m

Jun 30 2022n/an/a

-US$17m

Mar 31 2022n/an/a

-US$19m

Dec 31 2021US$4mUS$192k

-US$18m

Sep 30 2021n/an/a

-US$17m

Jun 30 2021n/an/a

-US$15m

Mar 31 2021n/an/a

-US$13m

Dec 31 2020US$23kn/a

-US$14m

Sep 30 2020n/an/a

-US$17m

Jun 30 2020n/an/a

-US$19m

Mar 31 2020n/an/a

-US$16m

Dec 31 2019US$79kn/a

-US$10m

Sep 30 2019n/an/a

-US$10m

Jun 30 2019n/an/a

-US$8m

Mar 31 2019n/an/a

-US$26m

Dec 31 2018US$107kn/a

-US$29m

Sep 30 2018n/an/a

-US$27m

Jun 30 2018n/an/a

-US$36m

Mar 31 2018n/an/a

-US$24m

Dec 31 2017US$140kn/a

-US$28m

Compensation vs Market: Dane's total compensation ($USD1.64M) is above average for companies of similar size in the US market ($USD649.07K).

Compensation vs Earnings: Dane's compensation has increased whilst the company is unprofitable.

CEO

Dane Andreeff (58 yo)

4.3yrs

Tenure

US$1,635,226

Compensation

Mr. Dane Carl Andreeff has been the President and Chief Executive Officer of Helius Medical Technologies, Inc. since June 14, 2021 and has been its Director since August 4, 2017. He is the Founder of Andre...

Leadership Team

NamePositionTenureCompensationOwnership
Dane Andreeff
President4.3yrsUS$1.64m0.00081%
$ 13.1
Jeffrey Mathiesen
CFO, Treasurer3.4yrsUS$1.06m0.0067%
$ 107.9
Antonella Favit-Van Pelt
Chief Medical Officer3.3yrsUS$786.54k0%
$ 0
Lawrence Picciano
Senior Vice President of Engineering2.8yrsno datano data

3.4yrs

Average Tenure

58yo

Average Age

Experienced Management: HSDT's management team is considered experienced (3.4 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Dane Andreeff
President7.3yrsUS$1.64m0.00081%
$ 13.1
Jeffrey Mathiesen
CFO, Treasurer2.5yrsUS$1.06m0.0067%
$ 107.9
Edward Straw
Independent Director10yrsUS$100.88k0.050%
$ 816.2
Paul Buckman
Independent Director3.2yrsUS$103.88k0.050%
$ 814.4
Robert Walter
Independent Chairman of the Board8.9yrsUS$118.88k0.053%
$ 857.9
Carl Hauser
Member of Scientific Advisory Board10yrsno datano data
Sherry Perkins
Independent Director3.7yrsUS$90.38kno data

7.3yrs

Average Tenure

65.5yo

Average Age

Experienced Board: HSDT's board of directors are considered experienced (7.3 years average tenure).